Given the variety of neuropathology in LRRK2-PD, in many cases being diverse (i.e., co-pathology), it remains to be elucidated whether aggregation is simply resultant to LRRK2-mediated cellular dysfunction or whether pathogenic LRRK2 activity plays a more direct role in driving inclusion formation. This evidence concerns the gene LRRK2 and Parkinson disease.